Pan Cancer T

Provider of TCR T-cell therapeutics for the treatment of cancer

placeRotterdam, South Holland, Netherlands calendar_todayFounded 2020 groups8 employees language pancancer-t.com

Social engagement

Social engagement: 2.1K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Swanbridge Capital, Van Herk Groep, Thuja Capital, InnovationQuarter.

Investor typeCountShare
Venture capital457%
Other / undisclosed343%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

2 Feb 2026 · Laboratory Research Technician – Cell Culture & Immunology · Leiden, Netherlands

Based on job postings tracked across public sources.

Recent activity

1 May 2026
Event
26th BioEquityEurope
15 Sep 2025
Milestone
anniversary
3 Jul 2025
Leadership hire
independent director
Coming soon